Emcure Pharmaceuticals Limited Share Price Today
Techno Funda Ratings
Key Metrics
Current Price
₹1783.2Market Cap
₹ 33,816 Cr.Stock P/E
35.8ROE
20.1 %RSI
40.37Trend
BullishShare Price Chart
Technical Commentary
Buy or Sell Analysis
Company Overview
Incorporated in 1981, Emcure Pharmaceuticals Ltd manufactures and markets pharmaceutical products globally[1]
Emcure Pharmaceuticals Ltd share price remains one of the actively tracked stocks on NSE among traders and long term investors.
The latest Emcure Pharmaceuticals Ltd share price NSE movement reflects ongoing investor interest driven by company fundamentals, sector performance and broader market sentiment.
From a technical analysis perspective, the Emcure Pharmaceuticals Ltd share price chart currently indicates a Bullish trend based on moving averages and RSI momentum analysis.
Technical Analysis
| Indicator | Value |
|---|---|
| Current Price | 1783.2 |
| RSI (14) | 40.37 |
| 50 DMA | 1759.72 |
| 200 DMA | 1542.41 |
| Trend | Bullish |
| A/D Rating | B |
| RS Rating | 81 |
| EPS Rating | 75 |
| TI65 | 1.04 |
| TI65 Trend | Neutral |
Pivot Points Analysis
Daily pivot points for Emcure Pharmaceuticals Limited calculated using previous trading session data. These levels help traders identify intraday support, resistance and breakout zones using Classic Pivot Point methodology.
Classic Pivot Points
| Level | Value |
|---|---|
| R3 | ₹1877.46 |
| R2 | ₹1845.73 |
| R1 | ₹1814.46 |
| PP | ₹1782.73 |
| S1 | ₹1751.46 |
| S2 | ₹1719.73 |
| S3 | ₹1688.46 |
Financial Ratios
| Metric | Value |
|---|---|
| Market Cap | ₹ 33,816 Cr. |
| Current Price | ₹ 1,783 |
| High / Low | ₹ 1,944 / 1,260 |
| Stock P/E | 35.8 |
| Book Value | ₹ 261 |
| Dividend Yield | 0.17 % |
| ROCE | 24.0 % |
| ROE | 20.1 % |
| Face Value | ₹ 10.0 |
Quarterly Results
| Quarter | Sales | Profit | OPM |
|---|---|---|---|
| Jun 2023 | 1,556 | 141 | 19% |
| Sep 2023 | 1,663 | 146 | 20% |
| Dec 2023 | 1,668 | 120 | 18% |
| Mar 2024 | 1,771 | 121 | 18% |
| Jun 2024 | 1,815 | 153 | 19% |
| Sep 2024 | 2,002 | 202 | 19% |
| Dec 2024 | 1,963 | 156 | 18% |
| Mar 2025 | 2,116 | 197 | 19% |
| Jun 2025 | 2,101 | 215 | 20% |
| Sep 2025 | 2,270 | 251 | 21% |
| Dec 2025 | 2,363 | 231 | 21% |
| Mar 2026 | 2,470 | 244 | 19% |
Shareholding Pattern
| Holder | Holding |
|---|---|
| Promoters | 77.92% |
| FIIs | 3.06% |
| DIIs | 3.44% |
| Public | 15.58% |
| No. of Shareholders | 1,39,671 |
Pros and Cons
Pros
- Healthy return on equity of 20.1% indicating strong capital allocation efficiency.
- Strong technical momentum with price holding comfortably above the 50 DMA (1759.72).
- Outperforming over 70% of the entire market universe over the past 12 months.
Cons
Related NSE Stocks
Garden Reach Shipbuilders & Engineers Limited
View Share Price Analysis →FORCE MOTORS LTD
View Share Price Analysis →JSW Dulux Limited
View Share Price Analysis →Exide Industries Limited
View Share Price Analysis →Gland Pharma Limited
View Share Price Analysis →Welspun Corp Limited
View Share Price Analysis →Bank of Baroda
View Share Price Analysis →JM Financial Limited
View Share Price Analysis →Ramkrishna Forgings Limited
View Share Price Analysis →Punjab National Bank
View Share Price Analysis →Cohance Lifesciences Limited
View Share Price Analysis →Aditya Birla Fashion and Retail Limited
View Share Price Analysis →Frequently Asked Questions
What is the current technical trend and RSI for Emcure Pharmaceuticals Ltd share?
Based on the latest closing data, the technical momentum for Emcure Pharmaceuticals Ltd is currently evaluated as Bullish. The stock is exhibiting an RSI (14) of 40.37, indicating it is trading in a neutral balanced zone. Key tracking supports are currently located near the daily pivots, with price relative to the 50 DMA (1759.72) defining immediate multi-day trend patterns.
What are the key resistance and support pivot points for Emcure Pharmaceuticals Ltd?
According to Classic Pivot Point methodologies, the core trading floor for Emcure Pharmaceuticals Ltd today centers at a Pivot Point (PP) of ₹1782.73. Upside resistance challenges are calculated at R1: ₹1814.46, R2: ₹1845.73, and R3: ₹1877.46. Conversely, if selling pressure intensifies, immediate floor support targets are positioned at S1: ₹1751.46, S2: ₹1719.73, and S3: ₹1688.46.
How does the fundamental ROE and P/E ratio look for Emcure Pharmaceuticals Ltd?
Emcure Pharmaceuticals Ltd is currently trading with a valuation metrics context of a Stock P/E of 35.8, against a core structural efficiency Return on Equity (ROE) standing at 20.1 %. This fundamental operational efficiency baseline is coupled with an EPS Rating of 75, allowing investors to track how corporate profitability trends align with current price discovery cycles on the National Stock Exchange (NSE).
Should I buy or sell Emcure Pharmaceuticals Ltd shares based on corporate rankings?
Our dynamic trade matrix suggests a status of: Strong Technical and Fundamental Buy Setup (High-Velocity Growth). Emcure Pharma... For long-term portfolios, decision-making should match the stock's market performance profile, which currently displays an institutional Accumulation/Distribution (A/D) grade of B, a Relative Strength (RS) ranking of 82, and long-term trend backing from the TI65 indicator (Neutral pattern).